Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.62
02.12.21
-
02.12.22
45.82%
12.12.21

Risky Investment
buy
Drone Delivery Canada Corp.

Start price
Target price
Perf. (%)
€1.30
11.02.21
€2.50
11.02.22
-54.92%
07.12.21

Could be very worthwhile Investment >20% year
Leading role in innovation
Strong uniques
Good culture
Paramount Resources Ltd. A

Start price
Target price
Perf. (%)
€16.80
15.11.21
-
15.11.22
-10.12%
06.12.21

Could be worthwhile Investment >10% per year
buy
Renegade Gold Inc.

Start price
Target price
Perf. (%)
€10.60
05.12.20
€17.00
05.12.21
-48.68%
06.12.21

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Management is a major shareholder
buy
Nuvo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.94
15.09.21
€1.20
15.09.22
11.23%
05.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher risks for its business
Below average Marketposition
buy
American Lithium Corp

Start price
Target price
Perf. (%)
€4.42
15.11.21
€5.00
15.11.22
-15.99%
27.11.21

EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
negative Cash Flow expected
DeFi Technologies

Start price
Target price
Perf. (%)
€2.67
02.11.21
-
02.11.22
-11.88%
23.11.21

Risky Investment
buy
Osisko Metals Inc

Start price
Target price
Perf. (%)
€0.23
15.11.20
€0.40
15.11.21
14.53%
16.11.21

Could be very worthwhile Investment >20% year
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€6.15
21.09.20
€4.00
04.11.21
17.07%
05.11.21

Probably not worthwhile Investment
High valuation
buy
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.01
28.04.20
€1.00
04.11.21
35.05%
05.11.21

Could be very worthwhile Investment >20% year
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€2.80
04.01.20
-
04.11.21
112.50%
05.11.21

Could be worthwhile Investment >10% per year
buy
Sonoro Gold Corp.

Start price
Target price
Perf. (%)
€0.12
25.02.19
€0.15
04.11.21
3.39%
05.11.21

buy
Rogers Sugar Inc.

Start price
Target price
Perf. (%)
€4.21
19.07.17
€4.35
04.11.21
-7.84%
05.11.21

buy
Jaxon Mining Inc

Start price
Target price
Perf. (%)
€0.087
26.05.17
€0.24
04.11.21
-53.97%
05.11.21

buy
Modern Plant Based Foods Inc.

Start price
Target price
Perf. (%)
€2.34
20.01.21
€1.90
20.01.22
-51.70%
01.11.21

Could be worthwhile Investment >10% per year
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.89
15.09.21
€5.85
15.09.22
1.27%
22.10.21

Could be very worthwhile Investment >20% year
Future proof or reliable business model
Higher risks for its business
buy
Rogue Resources Inc.

Start price
Target price
Perf. (%)
€0.050
19.01.19
€0.20
04.11.21
41.00%
17.10.21

buy
Aya Gold & Silver Inc.

Start price
Target price
Perf. (%)
€5.35
04.10.21
-
04.10.22
20.56%
15.10.21

Could be very worthwhile Investment >20% year
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
13.10.21
€8.50
13.10.22
-1.14%
13.10.21

Leading role in innovation
Capable Management
Good culture
Strong uniques
buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€8.53
20.09.21
-
20.09.22
-27.86%
02.10.21

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
buy
Aya Gold & Silver Inc.

Start price
Target price
Perf. (%)
€5.90
20.09.21
-
20.09.22
-9.32%
02.10.21

Could be very worthwhile Investment >20% year
buy
Jackpot Digital Inc.

Start price
Target price
Perf. (%)
€0.14
27.07.21
-
27.07.22
-57.85%
28.09.21

Could be worthwhile Investment >10% per year
buy
Aya Gold & Silver Inc.

Start price
Target price
Perf. (%)
€6.80
06.09.21
-
06.09.22
-13.24%
18.09.21

Could be very worthwhile Investment >20% year
Sphere 3D Corp.

Start price
Target price
Perf. (%)
€38.50
04.09.21
€14.00
04.09.22
-0.91%
18.09.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
ESSA Pharma Inc

Start price
Target price
Perf. (%)
€6.85
16.08.21
-
16.08.22
-0.73%
22.08.21

Risky Investment